PRCT - רווח נקי למניה (EPS TTM) PROCEPT BioRobotics Inc

The high margins of PROCEPT BioRobotics (PRCT) are based on the sale of consumables for urological robots. The rolling unit profit history clearly demonstrates the dynamics of this process, where the value of -2.03 captures the metric level. The precision of AI technologies makes the system a surgical benchmark, while expansion into global markets and an increasing number of installations create powerful potential for further business scaling.

This indicator measures the annual net profit per share, allowing for an assessment of real business efficiency without the influence of market volatility. By analyzing the rolling 12-month net income per share on GURU.Markets, an investor can compare the capitalization rates of PROCEPT BioRobotics (PRCT) with revenues from the sale of robotic systems and recurring sales of consumables in urological centers.